Evidence map›Paper›PMID 26701976›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.

Mingjun Shi, Brianna Flores, Nancy Gillings, Ao Bian, Han Jun Cho, Shirley Yan, Yang Liu, Beth Levine, Orson W Moe, Ming Chang Hu

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. Correlation between SolubleBioMed research international · 2018
    Pooled it
  2. Article
  3. Observational
  4. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Current Controversies on Adequate Circulating Vitamin D Levels in CKD.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. MondoA and AKI and AKI-to-CKD Transition.Journal of the American Society of Nephrology : JASN · 2024
    Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Mingjun ShiCharles and Jane Pak Center for Mineral Metabolism and Clinical Research.
Brianna FloresCharles and Jane Pak Center for Mineral Metabolism and Clinical Research.
Nancy GillingsCharles and Jane Pak Center for Mineral Metabolism and Clinical Research.
Ao BianCharles and Jane Pak Center for Mineral Metabolism and Clinical Research.
Han Jun ChoCharles and Jane Pak Center for Mineral Metabolism and Clinical Research.
Shirley YanDepartments of Pathology.
Yang LiuInternal Medicine, Center for Autophagy Research, and.
Beth LevineInternal Medicine, Center for Autophagy Research, and Microbiology, and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas.
Orson W MoeCharles and Jane Pak Center for Mineral Metabolism and Clinical Research, Internal Medicine, Physiology, orson.moe@utsouthwestern.edu ming-chang.hu@utsouthwestern.edu.
Ming Chang HuCharles and Jane Pak Center for Mineral Metabolism and Clinical Research, Internal Medicine, orson.moe@utsouthwestern.edu ming-chang.hu@utsouthwestern.edu.
Montavid Thermodynamic Research Group · HUThe University of Texas Southwestern Medical Center · US

Funding

Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney InjuryR01DK092461 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HU, MING-CHANG · 2011 to 2021
$3.7M
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and TherapeuticsR01DK091392 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HU, MING-CHANG, MOE, ORSON W · 2011 to 2021
$3.2M
NIDDK NIH HHS R01 DK091392NIDDK NIH HHS R01 DK092461
6 · The paper itself

Abstract

AKI confers increased risk of progression to CKD. αKlotho is a cytoprotective protein, the expression of which is reduced in AKI, but the relationship of αKlotho expression level to AKI progression to CKD has not been studied. We altered systemic αKlotho levels by genetic manipulation, phosphate loading, or aging and examined the effect on long-term outcome after AKI in two models: bilateral ischemia-reperfusion injury and unilateral nephrectomy plus contralateral ischemia-reperfusion injury. Despite apparent initial complete recovery of renal function, both types of AKI eventually progressed to CKD, with decreased creatinine clearance, hyperphosphatemia, and renal fibrosis. Compared with wild-type mice, heterozygous αKlotho-hypomorphic mice (αKlotho haploinsufficiency) progressed to CKD much faster, whereas αKlotho-overexpressing mice had better preserved renal function after AKI. High phosphate diet exacerbated αKlotho deficiency after AKI, dramatically increased renal fibrosis, and accelerated CKD progression. Recombinant αKlotho administration after AKI accelerated renal recovery and reduced renal fibrosis. Compared with wild-type conditions, αKlotho deficiency and overexpression are associated with lower and higher autophagic flux in the kidney, respectively. Upregulation of autophagy protected kidney cells in culture from oxidative stress and reduced collagen 1 accumulation. We propose that αKlotho upregulates autophagy, attenuates ischemic injury, mitigates renal fibrosis, and retards AKI progression to CKD.

Indexed as

Disease ProgressionAcute Kidney InjuryAnimalsAutophagyGlucuronidaseKlotho ProteinsMiceReceptors, Cell SurfaceRenal Insufficiency, ChronicGlucuronidaseKlotho ProteinsReceptors, Cell Surfaceacute kidney injuryautophagychronic kidney diseaseischemia-reperfusion injuryrenal fibrosisαKlotho

Identifiers

PMID26701976
PMCPMC4978045
OpenAlexW2238892474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.